Skip to search formSkip to main contentSkip to account menu

Loss of Chromosome 9q

Known as: del(9q) 
A cytogenetic abnormality that refers to deletion of part of the long arm of chromosome 9. It is associated with the development of acute myeloid… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
To the editor: RUNX1 (also known as AML1 or CBFA2 ) and CBFB encode the α and β subunits of a heterodimeric core binding… 
Highly Cited
2012
Highly Cited
2012
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients 
Highly Cited
2010
Highly Cited
2010
PURPOSE Because cytogenetic data are essential for risk stratification of childhood acute myeloid leukemia (AML), the impact of… 
Highly Cited
2009
Highly Cited
2009
Acute myeloid leukemia (AML) with mutated NPM1 usually carries normal karyotype (NK), but it may harbor chromosomal aberrations… 
Review
2008
Review
2008
Purpose of review Core-binding factor (CBF) acute myeloid leukemia (AML) is among the most common cytogenetic subtypes of AML… 
Highly Cited
2008
Highly Cited
2008
Deletions on chromosome 9q are seen in a subset of acute myeloid leukemia (AML) cases and are specifically associated with t(8;21… 
Highly Cited
2007
Highly Cited
2007
We have generated a large, unique database that includes morphologic, clinical, cytogenetic, and follow-up data from 2124… 
Highly Cited
1998
Highly Cited
1998
Cytogenetics is considered one of the most valuable prognostic determinants in acute myeloid leukemia (AML). However, many… 
Review
1994
Review
1994
Secondary chromosomal aberrations reported in the literature were surveyed in acute myeloid or lymphoblastic leukemia (AML or ALL… 
Highly Cited
1986
Highly Cited
1986